Radiation-recall enteritis after actinomycin-D and adriamycin therapy

Area of Science:

• Oncology
• Gastroenterology
• Radiation Oncology

Background:

• Testicular tumors can metastasize to retroperitoneal lymph nodes, requiring multimodal treatment.
• Radiation therapy is a common modality for treating such metastatic disease.
• Chemotherapy agents like actinomycin-D and adriamycin are used in testicular cancer treatment.

Observation:

• A 22-year-old male patient presented with four distinct episodes of small bowel obstruction.
• These obstructions consistently occurred after courses of chemotherapy.
• Surgical intervention revealed vascular changes indicative of radiation injury.

Findings:

• The patient's clinical course suggests a rare phenomenon known as radiation recall injury.
• The small bowel appears to be the affected site in this case.
• The specific chemotherapy agents, actinomycin-D and adriamycin, were implicated in triggering the recall.

Implications:

• This case highlights the potential risk of radiation recall injury in patients with prior radiation exposure.
• The choice of chemotherapy, particularly actinomycin-D and adriamycin, should consider the patient's radiation history.
• Careful patient selection and monitoring are crucial when administering chemotherapy after radiation therapy to minimize tissue injury risk.